Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Bansback

Showing results (1-10 of 202) with videos related to

Pageof 21
Sort By:
Journal of Clinical Epidemiology|January 21, 2017
Moving from outcomes to values to deliver high-quality health care-A new checklist for valuation studiesLogan Trenaman, Nick Bansback
Sleep|September 3, 2013
Long-term effectiveness of oral appliance versus CPAP therapy and the emerging importance of understanding patient preferencesFernanda R Almeida, Nick Bansback
Arthritis and Rheumatism|February 28, 2009
Now that we know what's BeSt, what is good value for the money?Nick Bansback, Carlo A Marra
Annals of the Rheumatic Diseases|August 2, 2012
Understanding the side effects of glucocorticoid therapy: shining a light on a drug everyone thinks they knowWilliam G Dixon, Nick Bansback
Healthcare (Amsterdam, Netherlands)|August 8, 2015
The cost-effectiveness of patient decision aids: A systematic reviewLogan Trenaman, Stirling Bryan, Nick Bansback
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 26, 2015
Does Introducing Imprecision around Probabilities for Benefit and Harm Influence the Way People Value Treatments?Nick Bansback, Mark Harrison, Carlo Marra
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 30, 2016
Improving patient-centred care for rheumatoid arthritisNick Bansback, Kam Shojania, Diane Lacaille
Rheumatology (Oxford, England)|January 23, 2008
Infliximab, etanercept and adalimumab for the treatment of ankylosing spondylitis: cost-effectiveness evidence and NICE guidanceAllan Wailoo, Nick Bansback, Jim Chilcott
Patient Education and Counseling|July 4, 2015
Physician attitudes toward shared decision making: A systematic reviewSamantha Pollard, Nick Bansback, Stirling Bryan
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 29, 2004
Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK. How important is quality of life?Nick Bansback, Sue Ward, Jon Karnon
Pageof 21

Showing results (1-10 of 202) with videos related to

Sort By:
Pageof 21
Journal of Clinical Epidemiology|January 21, 2017
Moving from outcomes to values to deliver high-quality health care-A new checklist for valuation studiesLogan Trenaman, Nick Bansback
Sleep|September 3, 2013
Long-term effectiveness of oral appliance versus CPAP therapy and the emerging importance of understanding patient preferencesFernanda R Almeida, Nick Bansback
Arthritis and Rheumatism|February 28, 2009
Now that we know what's BeSt, what is good value for the money?Nick Bansback, Carlo A Marra
Annals of the Rheumatic Diseases|August 2, 2012
Understanding the side effects of glucocorticoid therapy: shining a light on a drug everyone thinks they knowWilliam G Dixon, Nick Bansback
Healthcare (Amsterdam, Netherlands)|August 8, 2015
The cost-effectiveness of patient decision aids: A systematic reviewLogan Trenaman, Stirling Bryan, Nick Bansback
Medical Decision Making : an International Journal of the Society for Medical Decision Making|August 26, 2015
Does Introducing Imprecision around Probabilities for Benefit and Harm Influence the Way People Value Treatments?Nick Bansback, Mark Harrison, Carlo Marra
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 30, 2016
Improving patient-centred care for rheumatoid arthritisNick Bansback, Kam Shojania, Diane Lacaille
Rheumatology (Oxford, England)|January 23, 2008
Infliximab, etanercept and adalimumab for the treatment of ankylosing spondylitis: cost-effectiveness evidence and NICE guidanceAllan Wailoo, Nick Bansback, Jim Chilcott
Patient Education and Counseling|July 4, 2015
Physician attitudes toward shared decision making: A systematic reviewSamantha Pollard, Nick Bansback, Stirling Bryan
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 29, 2004
Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK. How important is quality of life?Nick Bansback, Sue Ward, Jon Karnon
Pageof 21